These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 10775547

  • 21. Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods.
    Hobart J, Cano S.
    Health Technol Assess; 2009 Feb; 13(12):iii, ix-x, 1-177. PubMed ID: 19216837
    [Abstract] [Full Text] [Related]

  • 22. Quantitative measures detect sensory and motor impairments in multiple sclerosis.
    Newsome SD, Wang JI, Kang JY, Calabresi PA, Zackowski KM.
    J Neurol Sci; 2011 Jun 15; 305(1-2):103-11. PubMed ID: 21458828
    [Abstract] [Full Text] [Related]

  • 23. Validity and reliability of the International Cooperative Ataxia Rating Scale (ICARS) and the Scale for the Assessment and Rating of Ataxia (SARA) in multiple sclerosis patients with ataxia.
    Salcı Y, Fil A, Keklicek H, Çetin B, Armutlu K, Dolgun A, Tuncer A, Karabudak R.
    Mult Scler Relat Disord; 2017 Nov 15; 18():135-140. PubMed ID: 29141795
    [Abstract] [Full Text] [Related]

  • 24. The SF-36 in multiple sclerosis: why basic assumptions must be tested.
    Hobart J, Freeman J, Lamping D, Fitzpatrick R, Thompson A.
    J Neurol Neurosurg Psychiatry; 2001 Sep 15; 71(3):363-70. PubMed ID: 11511712
    [Abstract] [Full Text] [Related]

  • 25. Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional Composite.
    Hobart J, Kalkers N, Barkhof F, Uitdehaag B, Polman C, Thompson A.
    Mult Scler; 2004 Feb 15; 10(1):41-6. PubMed ID: 14760951
    [Abstract] [Full Text] [Related]

  • 26. Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples.
    Riazi A, Hobart JC, Lamping DL, Fitzpatrick R, Thompson AJ.
    J Neurol Neurosurg Psychiatry; 2002 Dec 15; 73(6):701-4. PubMed ID: 12438473
    [Abstract] [Full Text] [Related]

  • 27. Cross-cultural adaptation, validity and reliability of the Turkish version of the patient determined disease steps scale in persons with multiple sclerosis.
    Kahraman T, Özdoğar AT, Özakbaş S.
    Physiother Theory Pract; 2021 Apr 15; 37(4):527-534. PubMed ID: 31218917
    [Abstract] [Full Text] [Related]

  • 28. The multiple sclerosis functional composite: a clinically meaningful measure of disability.
    Polman CH, Rudick RA.
    Neurology; 2010 Apr 27; 74 Suppl 3():S8-15. PubMed ID: 20421572
    [Abstract] [Full Text] [Related]

  • 29. Relapses add to permanent disability in relapsing multiple sclerosis patients.
    Koch-Henriksen N, Sørensen PS, Magyari M.
    Mult Scler Relat Disord; 2021 Aug 27; 53():103029. PubMed ID: 34116481
    [Abstract] [Full Text] [Related]

  • 30. Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12).
    Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ.
    Neurology; 2003 Jan 14; 60(1):31-6. PubMed ID: 12525714
    [Abstract] [Full Text] [Related]

  • 31. Psychometric Properties of a Core Set of Measures of Balance for People With Cerebellar Ataxia Secondary to Multiple Sclerosis.
    Winser S, Smith CM, Hale LA, Claydon LS, Whitney SL, Klatt B, Mottershead J, Zaydan I, Heyman R.
    Arch Phys Med Rehabil; 2017 Feb 14; 98(2):270-276. PubMed ID: 27577181
    [Abstract] [Full Text] [Related]

  • 32. Changes in the Risk of Reaching Multiple Sclerosis Disability Milestones In Recent Decades: A Nationwide Population-Based Cohort Study in Sweden.
    Beiki O, Frumento P, Bottai M, Manouchehrinia A, Hillert J.
    JAMA Neurol; 2019 Jun 01; 76(6):665-671. PubMed ID: 30882868
    [Abstract] [Full Text] [Related]

  • 33. Reliability of televisits for patients with mild relapsing-remitting multiple sclerosis in the COVID-19 era.
    Toscano S, Patti F, Chisari CG, Arena S, Finocchiaro C, Schillaci CE, Zappia M.
    Neurol Sci; 2022 Apr 01; 43(4):2253-2261. PubMed ID: 35018548
    [Abstract] [Full Text] [Related]

  • 34. How similar are commonly combined criteria for EDSS progression in multiple sclerosis?
    Kragt JJ, Nielsen IM, van der Linden FA, Uitdehaag BM, Polman CH.
    Mult Scler; 2006 Dec 01; 12(6):782-6. PubMed ID: 17263007
    [Abstract] [Full Text] [Related]

  • 35. Continuous daily assessment of multiple sclerosis disability using remote step count monitoring.
    Block VJ, Lizée A, Crabtree-Hartman E, Bevan CJ, Graves JS, Bove R, Green AJ, Nourbakhsh B, Tremblay M, Gourraud PA, Ng MY, Pletcher MJ, Olgin JE, Marcus GM, Allen DD, Cree BA, Gelfand JM.
    J Neurol; 2017 Feb 01; 264(2):316-326. PubMed ID: 27896433
    [Abstract] [Full Text] [Related]

  • 36. Modelling the natural history of primary progressive multiple sclerosis.
    Harding KE, Wardle M, Moore P, Tomassini V, Pickersgill T, Ben-Shlomo Y, Robertson NP.
    J Neurol Neurosurg Psychiatry; 2015 Jan 01; 86(1):13-9. PubMed ID: 24828900
    [Abstract] [Full Text] [Related]

  • 37. Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis.
    Ozakbas S, Cagiran I, Ormeci B, Idiman E.
    J Neurol Sci; 2004 Mar 15; 218(1-2):3-7. PubMed ID: 14759626
    [Abstract] [Full Text] [Related]

  • 38. Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations.
    Petzold A, Eikelenboom MJ, Gveric D, Keir G, Chapman M, Lazeron RH, Cuzner ML, Polman CH, Uitdehaag BM, Thompson EJ, Giovannoni G.
    Brain; 2002 Jul 15; 125(Pt 7):1462-73. PubMed ID: 12076997
    [Abstract] [Full Text] [Related]

  • 39. Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome.
    Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ.
    Health Technol Assess; 2004 Mar 15; 8(9):iii, 1-48. PubMed ID: 14982653
    [Abstract] [Full Text] [Related]

  • 40. The reliability and validity of the Turkish version of the apraxia screen of TULIA in multiple sclerosis patients.
    Yıldız Z, Doymaz F, Özden F.
    Disabil Rehabil; 2022 Dec 15; 44(25):8042-8047. PubMed ID: 34898347
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.